Search
for
Sort by
Research 481–510 of 1000+
- Mesenchymal Stem Cells from Adipose Tissue in Clinical Applications for Dermatological Indications and Skin Aging
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Alopecia areata: medical treatments
- Activating an adaptive immune response from a hydrogel scaffold imparts regenerative wound healing
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- The role of the microbiome in scalp hair follicle biology and disease
- Human ClinicalPhenotype Associated with FOXN1 Mutations
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- The Multi-Faceted Role of Gut Microbiota in Alopecia Areata
- Hair follicle-derived melanocyte transplant as a promising treatment strategy for vitiligo
- Summary of the Preceding Three Alopecia Areata Research Summits: What’s Past Is Prologue
- Revealing biological mechanisms of skin pigment recovery during treatment in vitiligo patients: A proteomic analysis
- An Anti-Inflammatory and Pro-Angiogenic Porous Aloe Polysaccharide-Collagen Dressing Accelerates Wound Healing
- Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Redefining the Skin Barrier: A Microbiome‐Integrated Multilayered Defense Model
- Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.
- Folate receptor β performs an immune checkpoint function in activated macrophages
- Intranasal sensitization model of alopecia areata using pertussis toxin as adjuvant
- Overview of the Role of 308 Monochromatic Excimer Phototherapy for the Treatment of Alopecia Areata
- COVID-19 and Sex Differences
- Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation